Presenters
Sonia Arrison, 100 Plus Capital
Sonia Arrison is an entrepreneur, investor, and best-selling author. She is founder of 100 Plus Capital, Chair of the Alliance for Longevity Initiatives, advisor to Felicis Ventures, and advisor to Bioverge, which invests at the convergence of biology and technology….
Progress on Health Extension in 2021 with Sonia Arrison, 100 Plus Capital
- 10k Youtube subscribers
- Seminar summaries have been created for all the Foresight seminars
- Longevity technology tree is being developed
- 2021 Biotech Foresight Fellows are JJ Ben Joseph and Stephen Malina
- Foresight Accelerator is supporting Daniel Ives, Jean Hebert, and Emil Kendziorra
- LAB NFT art gallery for fundraising
- The seminars were very comprehensive
- We need to start measuring aging in young people
- The lineup of discussions was extremely diverse in thought
- Submeetings on investing, policy, and experimental approaches will be started next year
- Alliance for Longevity Initiatives political group can attribute its start to a Foresight Institute meeting
- A longevity caucus is planned
- Michael Levin’s talk was extremely interesting
- Daniel Ives has some gene candidates which are ready for testing
- Emil Kendziorra is about to open an institute for cryonics in Switzerland
- Global meetups are happening next year on a monthly basis
- Vision Weekend was an incredible experience
- Longevity seems to be coming of age now
- Brain research and longevity have significant overlap
- Regrowing the thymus, brain replacement therapy, and atherosclerosis research are up and coming
- There may be a workshop or competition for longevity biomarkers in 2022
- We need a lot more clinical trials
- Billions of dollars are being used to treat diseases of aging, but that money should go toward the underlying causes of aging
- Senolytics has been relatively successful, especially Quercetin and Dasatinib
- Foresight specializes at supporting work at the intersection of domains
- Next year is shaping up to be very exciting!